Related Experiment Videos
A headache and a mass lesion: vasculitis or CNS sarcoid?
1Dept. of Rheumatic and Immunologic Diseases, Cleveland Clinic Foundation, 9500 Euclid Avenue, Cleveland, Ohio 44195, USA. calabri@ccf.org
Clinical and Experimental Rheumatology
|January 27, 2004
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
The Intersection of COVID-19 and Autoimmunity: What is Our Current Understanding?
Pathogens & immunity·2021
ESCMID Study Group for Infections in Compromised Hosts (ESGICH) Consensus Document on the safety of targeted and biological therapies: an infectious diseases perspective (Soluble immune effector molecules [II]: agents targeting interleukins, immunoglobulins and complement factors).
Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases·2018
Menstrual Abnormalities, Nutritional Patterns, and Body Composition in Female Classical Ballet Dancers.
The Physician and sportsmedicine·2016
AIDS and Athletes.
The Physician and sportsmedicine·2016
HIV and Sports: What Is the Risk?
The Physician and sportsmedicine·2016
Outcome and risk factors for progression in IgG4-related disease under watchful waiting.
Clinical and experimental rheumatology·2026
Safety and procedural success of minor salivary gland biopsy in Sjögren's disease: a retrospective analysis of 202 patients.
Clinical and experimental rheumatology·2026
AI-augmented rheumatologist? Reflections on AI-induced technostress, job insecurity and professional identity.
Clinical and experimental rheumatology·2026
The role of phospholipase D4 in inflammatory autoimmune diseases.
Clinical and experimental rheumatology·2026
Risk factors and long-term follow-up in acute Kawasaki disease patients with medium or large coronary artery aneurysms.
Clinical and experimental rheumatology·2026
Advanced analytical approaches for endocannabinoids and endocannabinoid-like substances: Applications in liver disease research.
Journal of pharmaceutical analysis·2026
Eco-friendly stability-indicating HPLC method development, validation, and LC-MS-based characterization of degradation products of the polar drug imeglimin.
Journal of pharmaceutical sciences·2026
Identification of candidate microRNA biomarkers of mouse cholangiocyte injury by global miRNAome analysis.
Toxicology and applied pharmacology·2026